A Novel Breath Analysis Method for the Diagnosis of Heart Failure
JSHS · 2024
Overview
Currently, 6.2 million adults suffer from heart failure (HF), with only 30 -40% surviving one -year post - hospitalization and a 30 -day readmission rate of 23%. The urgent need for an affordable, specific, non - invasive, and portable screening test to rapidly diagnose HF has led to a novel diagnostic approach using breath analysis and machine learning. In this study, twenty -seven HF patients and thirty healthy controls were enrolled and provided exhaled breath samples through a microfabricated microreactor chip coated with 2-(aminooxy) ethyl-N,N,Ntrimethylammonium to capture carbonyl compounds in the breath. Carbonyl compounds were then analyzed by ultra -high performan ce liquid chromatography -mass spectrometry. There were unique metabolic fingerprints associated with HF, indicated by the altered concentrations and patterns of twelve carbonyl compounds. Patients with HF showed significantly higher levels of compounds such as acetone, pentanal, acetic acid, caproic acid, acrolein, and 3,4 methylenedioxyamphetamine while exhibiting lower levels of others like 2 -butanone, pentanone, ethyl propionate, cyclohexylacetone, methyl acrylate, and 4-hydroxy-2-hexenal compared to healthy controls. Sparse partial least squares discriminant analysis and 2D scores plot allowed complete differentiation of HF patients from healthy controls. Random forest machine learning algorithm achieved an average area under the curve of 0.99, validatin g the hypothesis and underscoring the potential of breath analysis combined with machine learning as a non - invasive diagnostic tool for HF. Top 5 features in the machine learning algorithms were acetone, cyclohexylacetone, pentanone, 2 -butanone and ethyl p ropionate. In conclusion, this study provides compelling evidence for the use of breath analysis and machine learning in diagnosing HF.
Competition history
- JSHS 2024
Resources
Related projects
ISEF · 2024
Development and Validation of a Novel Breath Analysis and Machine Learning Platform for Non-Invasive Diagnosis of Heart Failure
ISEF · 2025
Lung Cancer Diagnosis Using Exhaled VOC Data and Machine Learning
ISEF · 2023
Development and Validation of a Novel Clinical Diagnostic Platform With Breath Analysis and Machine Learning
ISEF · 2025
BreathInSight: Multi-Sensor Lung Health Analyzer for Early Detection of Respiratory Conditions
ISEF · 2021
Diagnosing the Stage of COVID-19 using Machine Learning on Breath Sounds
ISEF · 2021
Measuring Blood Glucose Level by Acetone Concentration in Exhaled Air
CWSF · 2026
NephroSense: Developing a Chronic Kidney Disease Screening Model for AI Breath Biomarker Testing
ISEF · 2025
VADAM: VOC Analyte Diagnostic Aid Machine
Closest projects by meaning, across every fair and year in the corpus.